Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Nomogram to Predict the Postoperative 1-, 3-, and 5-year Overall Sur-vival in Gastrointestinal Cancer Patients: A Retrospective Multicenter Cohort Study

NCT05620537 is registered in ClinicalTrials.gov with Wang Xinying as lead sponsor.

NCT NCT05620537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05620537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Nomogram to Predict the Postoperative 1-, 3-, and 5-year Overall Sur-vival in Gastrointestinal Cancer Patients: A Retrospective Multicenter Cohort Study
Lead sponsor
Wang Xinying
Phase
Observational
Overall status
Completed
Start date
November 10, 2022
Completion date
November 25, 2022
Enrollment
808 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal cancers - colorectal, gastrointestinal cancers - stomach, nutrition assessment, prognosis, survival analysis